Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for radiation-induced fatigue in breast cancer
IRCT20220907055912N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in breast cancer and Radiation-induced fatigue, sponsored by Shiraz University of Medical Sciences. Started Feb 2023; status: completed.
02
Drugs
melatonin
03
Conditions
breast cancerRadiation-induced fatigue
Beyond the preview
Go deeper on IRCT20220907055912N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220907055912N1.